Race, Ethnicity, and Diffuse Parenchymal Lung Disease
Completed
Conditions studied: Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Diffuse Parenchymal Lung Disease
In brief
The purpose of this study is to identify factors that contribute to higher mortality rates among blacks and Hispanics with diffuse parenchymal lung disease.
Key facts
- Study ID
- NCT00453713
- Run by
- Columbia University
- People needed
- 565
- Starts
- 2006-07-01
- Expected to finish
- 2013-08-01
- Last updated by the study team
- 2015-04-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of IPF or other DPLD according to ATS criteria
- Signed informed consent
You may not qualify if…
- None
Where it is running
- Columbia University Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.